Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
.refereed research
 |  |  |  |  | 


Open AccessHighly AccessResearch

Modeling synthetic lethality

Nolwenn Le Meur1,2 email and Robert Gentleman1 email

Fred Hutchinson Cancer Center Research, Program in Computational Biology, Division of Public Health Sciences, Fairview Avenue North, Seattle, WA 98109, USA

INSERM, IRISA Symbiose, Campus de Beaulieu, 35042 RENNES Cedex, France

author email corresponding author email

Genome Biology 2008, 9:R135doi:10.1186/gb-2008-9-9-r135

Published: 12 September 2008

Subject areas: Bioinformatics, Genetics, Model organisms

Abstract

Background

Synthetic lethality defines a genetic interaction where the combination of mutations in two or more genes leads to cell death. The implications of synthetic lethal screens have been discussed in the context of drug development as synthetic lethal pairs could be used to selectively kill cancer cells, but leave normal cells relatively unharmed. A challenge is to assess genome-wide experimental data and integrate the results to better understand the underlying biological processes. We propose statistical and computational tools that can be used to find relationships between synthetic lethality and cellular organizational units.

Results

In Saccharomyces cerevisiae, we identified multi-protein complexes and pairs of multi-protein complexes that share an unusually high number of synthetic genetic interactions. As previously predicted, we found that synthetic lethality can arise from subunits of an essential multi-protein complex or between pairs of multi-protein complexes. Finally, using multi-protein complexes allowed us to take into account the pleiotropic nature of the gene products.

Conclusions

Modeling synthetic lethality using current estimates of the yeast interactome is an efficient approach to disentangle some of the complex molecular interactions that drive a cell. Our model in conjunction with applied statistical methods and computational methods provides new tools to better characterize synthetic genetic interactions.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.